ESMO Preceptorship on Brain Tumours 2019 Lugano banner

Start date: 11 Oct 2019
End date: 12 Oct 2019
Location: Lugano, Switzerland

Learning objectives

To learn about the evidence-base for diagnostic imaging, molecular pathology and neurocognitive assessment in brain tumour patients
To understand the basis of multi-modality treatment of lower and higher-grade gliomas
To learn about local and systemic treatment options for meningiomas
To learn about the multi-modality management of brain metastasis patients including targeted therapies in patients with actionable driver mutations and with novel immunotherapies
To learn about future developments in the management of gliomas, meningiomas, brain metastases and leptomeningeal carcinomatosis

Accreditation

The programme of this event has been accredited with 8 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

Matthias Preusser, Austria
Michael Weller, Switzerland